Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | ELANE | P08246 | 1/20 | 0.35 |
| ▸ | GPR119 | Q8TDV5 | 5/20 | 0.34 |
| ▸ | LSS | P48449 | 3/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14478762 | 0.99 | KMT2A (0.36) | KMT2AATMELANEGPR119LSS | |
| SCHEMBL14727697 | 0.94 | THRB (0.34) | KMT2AATMELANEGPR119HPGD | |
| SCHEMBL14727686 | 0.93 | THRB (0.42) | KMT2AATMELANEGPR119LSS | |
| SCHEMBL14727684 | 0.93 | KMT2A (0.38) | KMT2AATMELANEGPR119LSS | |
| SCHEMBL14727675 | 0.92 | KMT2A (0.39) | KMT2AATMELANEGPR119HPGD | |
| SCHEMBL14727703 | 0.91 | GPR119 (0.36) | KMT2AATMELANEGPR119LSS | |
| SCHEMBL21074619 | 0.89 | LSS (0.33) | KMT2AGPR119LSSHPGDADORA3 | |
| SCHEMBL14727672 | 0.88 | KMT2A (0.40) | KMT2AATMELANEHPGDADORA3 | |
| SCHEMBL14727698 | 0.88 | THRB (0.35) | KMT2AATMELANEGPR119ADORA3 | |
| SCHEMBL14727705 | 0.87 | ELANE (0.38) | KMT2AELANEGPR119HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8840807-B2 | Polymerizable compound | JNC CORPORATION (JP) | 2014-09-23 | — | — | US | disclosed |
| US-8840807-B2 | Polymerizable compound | JNC CORPORATION (JP) | 2014-09-23 | — | — | US | disclosed |
| US-20130048912-A1 | POLYMERIZABLE COMPOUND | JNC PETROCHEMICAL CORPORATION (JP) | 2013-02-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130048912-A1 | POLYMERIZABLE COMPOUND | PYM1, ZYX, CPNE4 | KMT2A 617/4885ATM 2670/4885ELANE 2834/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.